1497 studies found for:    alzheimer
Show Display Options
Rank Status Study
41 Completed Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient
Condition: Alzheimer's Disease
Intervention: Biological: GSK933776
42 Completed
Has Results
Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine 5 and 10 cm^2 patch
43 Completed Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365 8.5 mg/kg;   Drug: Placebo
44 Completed Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II
Condition: Alzheimer Disease
Intervention:
45 Completed
Has Results
Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Memantine;   Drug: Placebo
46 Completed
Has Results
Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine 5 cm^2 transdermal patch;   Drug: Rivastigmine 10 cm^2 transdermal patch
47 Completed Improved Diagnosis of Alzheimer's Disease Using the Synchronous Neural Interaction™ Test
Condition: Alzheimer's Disease
Intervention:
48 Completed
Has Results
Citalopram for Agitation in Alzheimer's Disease
Conditions: Alzheimer's Disease;   Agitation
Interventions: Drug: citalopram;   Drug: placebo
49 Completed European Study of HF0220 in Mild to Moderate Alzheimer's Disease Patients
Condition: Alzheimer's Disease
Intervention: Drug: HF0220
50 Withdrawn A Study Of Oral PF-01913539 In Patients With Mild To Moderate Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia;   Dimebon;   Investigational Drug
Interventions: Drug: PF-01913539 5 mg;   Drug: Placebo
51 Completed A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease
Condition: Alzheimer´s Disease
Interventions: Drug: Immune Globulin Intravenous (Human), 10% (IGIV, 10%);   Other: Placebo solution
52 Not yet recruiting Evaluation of the Efficacy and Safety of TTP488 in Patients With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TTP488;   Drug: Placebo
53 Unknown  Contribution of Actigraphy and Recognition Video in Apathy Assessment of Alzheimer's Disease : Experimental Research
Condition: Alzheimer's Disease
Intervention: Other: Actigraphy and video recording signal
54 Active, not recruiting Detection of Disease-Related Changes in Pre-Symptomatic Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Other: Observational Study
55 Completed An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease.
Condition: Alzheimer Disease
Intervention: Drug: galantamine
56 Recruiting Alzheimer's Disease, Art and Garden
Condition: Alzheimer Disease
Intervention: Behavioral: Cognitive and psycho-behavioral effects of an artistic dimension
57 Active, not recruiting Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: AADvac1
58 Completed A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365 10 mg/kg;   Biological: PF-04360365 7.5 mg/kg;   Drug: placebo
59 Unknown  Evaluation of 3APS in Patients With Mild to Moderate Alzheimer’s Disease
Condition: Alzheimer Disease
Intervention: Drug: 3APS
60 Completed An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type
Condition: Alzheimer Disease
Intervention: Drug: NS 2330 (Tesofensine)

First Page    Show previous page of results Previous Page (21-40) Studies Shown (41-60) Next Page (61-80) Show next page of results    Last Page
Indicates status has not been verified in more than two years